scholarly article | Q13442814 |
P819 | ADS bibcode | 2000PNAS...97.6334T |
P356 | DOI | 10.1073/PNAS.97.12.6334 |
P932 | PMC publication ID | 18603 |
P698 | PubMed publication ID | 10841542 |
P5875 | ResearchGate publication ID | 12475855 |
P50 | author | Gilda Tachedjian | Q57006431 |
P2093 | author name string | S P Goff | |
H E Aronson | |||
P2860 | cites work | MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 |
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 | Q27729415 | ||
High resolution structures of HIV-1 RT from four RT-inhibitor complexes | Q27729427 | ||
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors | Q27729428 | ||
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase | Q27732211 | ||
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance | Q27766086 | ||
Raster3D: photorealistic molecular graphics | Q27860557 | ||
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 | ||
A novel genetic system to detect protein-protein interactions | Q27860915 | ||
Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
Site-specific mutagenesis of AIDS virus reverse transcriptase | Q28338101 | ||
Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine | Q28370846 | ||
A new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domains | Q28371255 | ||
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor | Q29547710 | ||
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B | Q29618922 | ||
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA | Q29620616 | ||
DNA specificity of the bicoid activator protein is determined by homeodomain recognition helix residue 9 | Q29620728 | ||
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. | Q34382153 | ||
Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer | Q35623899 | ||
Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system | Q36662251 | ||
Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation | Q36820531 | ||
Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase | Q38296391 | ||
The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer | Q38337436 | ||
Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization | Q38355667 | ||
Detection of protein-protein interactions using different vectors in the two-hybrid system | Q40411234 | ||
Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain | Q41468615 | ||
Chemical crosslinking of the subunits of HIV-1 reverse transcriptase. | Q42740741 | ||
Assays for retroviral reverse transcriptase | Q42831046 | ||
Protein-protein interactions of HIV-1 reverse transcriptase: implication of central and C-terminal regions in subunit binding | Q43867754 | ||
Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. | Q45860281 | ||
A leucine zipper-like motif may mediate HIV reverse transcriptase subunit binding | Q53759737 | ||
Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities | Q54686257 | ||
Generating yeast transcriptional activators containing no yeast protein sequences. | Q54699189 | ||
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. | Q55063317 | ||
Kinetic Analysis of Four HIV-1 Reverse Transcriptase Enzymes Mutated in the Primer Grip Region of p66 | Q59663006 | ||
Characterization of the dimerization process of HIV-1 reverse transcriptase heterodimer using intrinsic protein fluorescence | Q59663050 | ||
Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers | Q71606791 | ||
Structure/function studies of HIV-1 reverse transcriptase: Dimerization-defective mutant L289K | Q72105897 | ||
Mixed reconstitution of mutated subunits of HIV-1 reverse transcriptase coexpressed in Escherichia coli - two tags tie it up | Q74672747 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6334-6339 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase | |
P478 | volume | 97 |
Q33558367 | A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release |
Q36018893 | Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor |
Q40505430 | Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain |
Q42179793 | Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT. |
Q33954411 | Clathrin facilitates the morphogenesis of retrovirus particles. |
Q34163065 | Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding |
Q40199711 | Deterministic, compensatory mutational events in the capsid of foot-and-mouth disease virus in response to the introduction of mutations found in viruses from persistent infections |
Q42738742 | Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers |
Q36667876 | Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization |
Q45218379 | Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation |
Q59361002 | Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase |
Q48364835 | Functional characterization of chimeric reverse transcriptases with polypeptide subunits of highly divergent HIV-1 group M and O strains. |
Q52339973 | HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain. |
Q33911980 | High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations |
Q41500267 | Homodimerization of the p51 subunit of HIV-1 reverse transcriptase. |
Q35857486 | Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles |
Q42656358 | Ligand-dependent protein interactions of the estrogen receptors using the yeast two-hybrid system |
Q34976859 | Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules |
Q82613379 | Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging |
Q33911895 | Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer |
Q35868299 | Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression |
Q38632038 | Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection |
Q36297904 | Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase |
Q43774982 | Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase |
Q28469069 | Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol |
Q40613638 | Reverse transcriptase of Moloney murine leukemia virus binds to eukaryotic release factor 1 to modulate suppression of translational termination |
Q38358165 | Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization |
Q28551203 | Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target |
Q28074527 | Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability |
Q39822124 | Systematic study of the genetic response of a variable virus to the introduction of deleterious mutations in a functional capsid region |
Q37928913 | Targeting human immunodeficiency virus type 1 assembly, maturation and budding. |
Q40761812 | Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity |
Search more.